Literature DB >> 11750295

Alexithymia and depression: a 1-year follow-up study in outpatients with major depression.

S Saarijärvi1, J K Salminen, T B Toikka.   

Abstract

OBJECTIVE: To examine the changes in alexithymic features and depressive and other psychological distress symptoms during a 1-year follow-up among patients with major depression.
METHODS: The study population comprised 120 outpatients suffering from major depression. Diagnosis was made with Structured Clinical Interview (SCID-I) for DSM-III-R. The severity of depression was evaluated with the 17-item Hamilton Rating Scale for Depression (HAM-D), and self-reported depression with the Beck Depression Inventory (BDI-21). Alexithymic features were assessed with the Twenty-Item Toronto Alexithymia Scale (TAS-20). Self-reported psychological distress symptoms were evaluated with the Brief Symptom Inventory (BSI).
RESULTS: Measures of depression and distress were significantly lower at the follow-up than at the baseline, while the total TAS-20 scores did not change significantly during the follow-up. A closer examination revealed that various TAS-20 factors behaved differently. Changes in Factors 1 and 2 were associated with changes in mood, whereas those in Factor 3 were not. Additionally, recovery from depression was associated with decrease in alexithymic features.
CONCLUSION: Difficulties in identifying and in describing feelings are associated with changes in mood, while externally oriented thinking is not.

Entities:  

Mesh:

Year:  2001        PMID: 11750295     DOI: 10.1016/s0022-3999(01)00257-4

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  36 in total

1.  Alexithymia, depression, and cognition in patients with Parkinson's disease.

Authors:  Gulay Kenangil; Mehmet Demir; Esma Tur; Fusun Domac
Journal:  Acta Neurol Belg       Date:  2021-01-16       Impact factor: 2.396

2.  Alexithymia and 7.5-year incidence of compensated low back pain in 1207 urban public transit operators.

Authors:  Wolf E Mehling; Niklas Krause
Journal:  J Psychosom Res       Date:  2007-06       Impact factor: 3.006

3.  The mental health benefits of work: do they apply to poor single mothers?

Authors:  Denise Zabkiewicz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-04-15       Impact factor: 4.328

4.  Measuring Alexithymia via Trait Approach-I: A Alexithymia Scale Item Selection and Formation of Factor Structure.

Authors:  Arkun Tatar; Gaye Saltukoğlu; Seda Alioğlu; Sümeyye Çimen; Hülya Güven; Çağla Ebru Ay
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

5.  Alexithymia and Somatization in Depressed Patients: The Role of the Type of Somatic Symptom Attribution.

Authors:  Okan Taycan; Armağan Özdemir; Serap Erdoğan Taycan
Journal:  Noro Psikiyatr Ars       Date:  2017-01-19       Impact factor: 1.339

6.  Affect School for chronic benign pain patients showed improved alexithymia assessments with TAS-20.

Authors:  Eva O Melin; Hans O Thulesius; Bengt A Persson
Journal:  Biopsychosoc Med       Date:  2010-06-04

7.  The mental health benefits of work: do they apply to welfare mothers with a drinking problem?

Authors:  Denise Zabkiewicz; Laura A Schmidt
Journal:  J Behav Health Serv Res       Date:  2008-09-17       Impact factor: 1.505

8.  Metabolic mapping reveals sex-dependent involvement of default mode and salience network in alexithymia.

Authors:  L Colic; L R Demenescu; M Li; J Kaufmann; A L Krause; C Metzger; M Walter
Journal:  Soc Cogn Affect Neurosci       Date:  2015-09-04       Impact factor: 3.436

9.  The Relationship between Alexithymia and General Symptoms of Patients with Depressive Disorders.

Authors:  Ju Hee Kim; Seung Jae Lee; Hyo Deog Rim; Hea Won Kim; Geum Ye Bae; Sung Man Chang
Journal:  Psychiatry Investig       Date:  2008-09-30       Impact factor: 2.505

10.  Alexithymia and Stress Response Patterns among Patients with Depressive Disorders in Korea.

Authors:  Hea Won Kim; Hyo Deog Rim; Ju Hee Kim; Seung Jae Lee
Journal:  Psychiatry Investig       Date:  2009-03-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.